摘要
目的 :探讨使用酚妥拉明与硝普钠治疗冠心病合并心力衰竭的疗效。方法 :选取我院2014年2月至2014年5月期间收治的80例冠心病合并心力衰竭患者作为研究对象。随机将这些患者分为酚妥拉明组和硝普钠组,每组各40例患者。为酚妥拉明组患者使用甲磺酸酚妥拉明注射液进行治疗,为硝普钠组患者使用硝普钠注射液进行治疗。然后比较两组患者治疗的效果及不良反应的发生情况。结果 :经过治疗后,硝普钠组患者治疗的总有效率及不良反应的发生率均明显优于酚妥拉明组患者,差异显著,具有统计学意义(P<0.05)。结论:使用硝普钠治疗冠心病合并心力衰竭的疗效显著,安全性高。此治疗方法值得在临床上推广应用。
Objective: To investigate phentolamine and sodium nitroprusside emergency clinical efficacy of coronary heart disease with heart failure. Methods: 80 cases of coronary heart disease with heart failure patients for the study, and were randomly divided into groups phentolamine and sodium nitroprusside. Results: The total efficiency of sodium nitroprusside therapy and incidence of adverse reactions than phentolamine group, the difference between their groups were statistically significant (all P <0.05). Conclusion: The clinical efficacy of sodium nitroprusside emergency treatment of coronary heart disease with heart failure and better, and the relatively high degree of safety.
关键词
硝普钠
酚妥拉明
冠心病合并心力衰竭
SNP
phentolamine
coronary heart disease with heart failure
